Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV.
Assia L Angelova, Marc Aprahamian, Svitlana P Grekova, Amor Hajri, Barbara Leuchs, Nathalia A Giese, Christiane Dinsart, Alexia Herrmann, Ginette Balboni, Jean Rommelaere, Zahari Raykov
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.